Investment Q&A

Q: I'd appreciate your opinion/suggestions on a few companies that a GARP (Growth At Reasonable Price) style investor should find particularly attractive currently - ignoring sector diversification.

Thank you

Q: Good Morning: I saw an article in the Globe a few days ago about a firm called "Transcend" which is a program run by Provisus Wealth Management. Looks like the principal player is Chris Ambridge. They are advertising themselves as a "pay for performance" discretionary money manager where you pay a minimal account maintenance fee (25 basis points annually) and then a performance premium of 20% on account profits (or smaller losses). However, the 20% is apparently only on profits that are better than the performance of the appropriate market. So for Cdn. equities I assume that would be the TSX. Wondering if you know anything about this program, know any of the principals at the company, or have an opinion about the merits/demerits of this kind of account. At the moment, I am a self-directed investor using BMO Investorline. As always, thanks.

Q: Hi 5i team,

I am diversified in my portfolio but I need one more stock to round out my TFSA. From the companies listed can you please rank in order based on your highest conviction in the company to be able to execute shareholder value over the next 5 years.

Thanks as always,

Jon

Q: Planning to add 2 of the suggested utilities to a growth portfolio or alternates that you might suggest & the rationale. Thank you.

Q: Recent additions to the 5i portfolios have entered at about 3% weightings, in spite of healthy cash positions in BE and Growth; is this a change in philosophy from the customary 5% or is it your intention to normalize the weights at a more favourable entry point?

I would use the "My Watchlist" feature more if it had View/Edit/Delete functions as there may be some names I do not want to be alerted on forever, only temporarily.

Q: this is a comment not a question, I just read your response on nfi about it's share price drop. last nite i received a notice from td that nfi is issuing a prospectus secondary offering on a bought deal basis at $40.40 expecting to close sept 27. I assume these will be the shares from the said seller. why kick investors in the teeth to the tune of 5% when the stock has been averaging higher prices.

Q: What do you think of Theratechnologies at this time?

best,
linda

Q: Although very different companies in size and industry, which one in your opinion has the better growth profile over the next 3 to 5 years. Thanks.

Q: Given that most, if not all of your highly rated IT co's are software business solutions co's and diversified across many sectors, is there any need to apply a 'sector' limit to them. I know they may all move with the IT sector during rotations, but not on fundamental issues that affect all co's in some sectors e.g. resources. Applying a sector limit seems to be excluding many fine growth co's from a portfolio, at the expense of including less attractive co's in the quest to diversify sectors, but is this necessary? Why have a sector limit at all when the co's in question are themselves diversified?
Thanks, Peter.

Q: Hello from Calgary.
Amaya's next earnings are Nov 8. Wondering what your expectations are for their next quarterly release.
Brin

Q: Who's buying CXR? Up for a second day.

Carl

Q: If we hold IT shares in a regular discount broker with a canadian big six bank, will our shares automatically convert to the exchangeable shares if we don't do anything? Thanks.

Q: NFI fell very substantially this morning. We have well over 100% profit in our joint portfolio, and even more in our TFSAs. Hold on, or time to trim? - Ted

Q: I sent a question early that came back as private. If I indicated for the question to be private, that was my mistake. I would prefer it to be public as we all learn from each other's questions and your answers.
Thanks

Q: For the most part we (subscribers) seem to ask you questions on the same stocks in some sort of rotation that I have not quite figured out. So it must be time again to ask, what stocks are we not asking about (very frequently perhaps)that we should be considering for our portfolios?

As always, I appreciate your insights - my best performing stocks are generally ideas I've picked up here!

Q: Hi team: I wonder if you would recommend a buy at these prices of Sept 22.

Q: With gold producers tightly a liked to the process of gold, there seems to be a 1 to 5 ratio of impact (gold increases 1%, producers increase 5 or more %). Over the past few days we see spot increase or decrease without a symmetrical impact to producers. Can you comment on what else impacts the general sector or are the more sensitive to factors and in fact spot prices are trailing?

Thanks,

Eric

Q: What are the four or more good reasons to own Gilead Sciences today? What are their Pipeline or new drugs coming like today? What will their future best selling drug in revenues be?

Q: I am looking for a higher paying dividend ETF for income that isn't too high on financials as I also own some individual stocks. Can you please give me your analysis and opinion on ZDV vs XEI on growth, risk, stablity.
Thanks

Q: Please provide me your views on this stock. Thanks

Gerry